Increased vessel perfusion predicts the efficacy of immune checkpoint blockade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased vessel perfusion predicts the efficacy of immune checkpoint blockade

Published:2018-04-16 Issue:5 Volume:128 Page:2104-2115
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Zheng Xichen,Fang Zhaoxu,Liu Xiaomei,Deng Shengming,Zhou Pei,Wang Xuexiang,Zhang Chenglin,Yin Rongping,Hu Haitian,Chen Xiaolan,Han Yijie,Zhao Yun,Lin Steven H.,Qin Songbing,Wang Xiaohua,Kim Betty Y.S.,Zhou Penghui,Jiang Wen^ORCID,Wu Qingyu,Huang Yuhui^ORCID

Funder

the National Natural Science Foundation of China

the National Program on Key Research Project of China

the National Institute of Neurological Disorders and Stroke

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/96582/files/pdf

Reference46 articles.

1. Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future

2. The future of immune checkpoint therapy

3. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

4. Monitoring immune-checkpoint blockade: response evaluation and biomarker development

5. Molecular mechanisms of T cell co-stimulation and co-inhibition

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bibliometric analysis of drug resistance in immunotherapy for breast cancer: trends, themes, and research focus;Frontiers in Immunology;2024-08-12

2. Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer;BMJ Oncology;2024-08

3. Pericytes: jack-of-all-trades in cancer-related inflammation;Frontiers in Pharmacology;2024-07-17

4. Lymphocyte homing and recirculation with tumor tertiary lymphoid structure formation: predictions for successful cancer immunotherapy;Frontiers in Immunology;2024-07-15

5. Immune checkpoint inhibitors and radiotherapy in gastrointestinal cancer treatment;Український радіологічний та онкологічний журнал;2024-07-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3